Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name AK112
Trade Name
Synonyms AK 112|AK-112
Drug Descriptions

AK112 is a bispecific antibody that binds PD-1 and VEGFA, potentially resulting in decreased tumor growth (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 2515).

DrugClasses Immune Checkpoint Inhibitor 153 PD-L1/PD-1 antibody 101 VEGFA Antibody 3
CAS Registry Number NA
NCIT ID C170909


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AK112 AK112 0 1
AK112 + Carboplatin + Paclitaxel AK112 Carboplatin Paclitaxel 0 0
AK112 + Carboplatin + Pemetrexed Disodium AK112 Carboplatin Pemetrexed Disodium 0 0
AK112 + Docetaxel AK112 Docetaxel 0 0

Additional content available in CKB BOOST